Fourth Edition

ICD-9-CM Codes for Musculoskeletal Diseases

135 : Sarcoidosis
170 : Malignant neoplasm of bone and articular cartilage
171 : Malignant neoplasm of connective and other soft tissue
198 : Secondary malignant neoplasm of bone and bone marrow
203 : Multiple myeloma and immunoproliferative neoplasms
213 : Benign neoplasm of bone and articular cartilage
215 : Other benign neoplasm of connective and other soft tissue
238 : Neoplasm of uncertain behavior of other and unspecified sites and tissues; Connective and other soft tissue; Bone soft tissue and skin

Indirect Costs

Indirect costs measure disease impact in terms of lost wages due to disability or death.  Indirect costs, like medical care costs, can be estimated and calculated in total for all the medical conditions an individual has, and as the increment attributable solely to musculoskeletal conditions.

Lost Work Days

More than 35 million adults in the workforce with a musculoskeletal condition reported lost work days in the previous 12 months, totaling nearly 364 million days. Lost work days for persons with a musculoskeletal conditions accounted for more lost work days than any other major health condition, with workers losing an average of 10 days of work. Chronic circulatory conditions, including high blood pressure and heart conditions, accounted for 283 million lost work days, and were reported by an increasing share of the working age population.

Economic Cost

The healthcare utilization and economic cost of musculoskeletal diseases section looks at the burden of musculoskeletal conditions both on individuals who have them and the overall US economy.

 

Pages

Subscribe to Fourth Edition